Cargando…
New Perspectives on Micronised Purified Flavonoid Fraction in Chronic Venous Disease: From Microvalves to Clinical Effectiveness
The importance of chronic venous disease (CVD), as a cause of reduced quality of life and increased costs to healthcare systems, is expected to rise in parallel with population aging and the increasing prevalence of obesity. Venoactive drugs (VADs) are frequently used to treat the symptoms and signs...
Autores principales: | Bouskela, Eliete, Lugli, Marzia, Nicolaides, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464747/ https://www.ncbi.nlm.nih.gov/pubmed/35951224 http://dx.doi.org/10.1007/s12325-022-02218-x |
Ejemplares similares
-
Optimising Decision Making in Chronic Venous Disease Management with Micronised Purified Flavonoid Fraction
por: Ulloa, Jorge H.
Publicado: (2023) -
Improving Chronic Venous Disease Management with Micronised Purified Flavonoid Fraction: New Evidence from Clinical Trials to Real Life
por: Lurie, Fedor, et al.
Publicado: (2023) -
The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease
por: Nicolaides, Andrew N.
Publicado: (2020) -
Intramammary Infusion of Micronised Purified Flavonoid Fraction (MPFF) in Mastitis-Diagnosed Dairy Cows Naturally Infected by Staphylococcus spp. in the Late Lactation
por: Gutiérrez-Reinoso, Miguel A., et al.
Publicado: (2023) -
Effects of Intrauterine Infusion of Micronised Purified Flavonoid Fraction (MPFF) in Metritis-Diagnosed Dairy Cows Naturally Infected by E. coli during the Early Postpartum
por: Gutiérrez-Reinoso, Miguel A., et al.
Publicado: (2022)